Search

Learn how to keep your immune system balanced.

… Wednesday, December 22, 2021 You may have read articles or seen products that claim to “boost” your immune system. But what does that mean — and is it even the right goal? Contrary to popular belief, our bodies don’t have one singular immune system. The immune system is actually made up of many different

In 2024, the MSK Giving community raised $511 million to advance MSK’s mission of ending cancer for life — every single dollar donated is making a real difference in the way we treat and understand cancer.

… Friday, June 6, 2025 In 2024, we invited the MSK Giving community to join an ambitious effort to raise $6 billion by 2030 and shape the future of cancer care — The MSK Campaign: Leading Science. Changing Lives .  In response, MSK donors contributed $511 million to advance MSK’s mission of ending cancer

Developmental biologist Maria Jasin studies homologous recombination, which is important in DNA repair and can lead to cancer when it malfunctions.

… Friday, July 1, 2011 Summary Developmental biologist Maria Jasin studies homologous recombination, which is important in DNA repair and can lead to cancer when it malfunctions. When chromosomes are copied and divided faithfully and no DNA damage is passed on, a parent cell gives rise to two identical

Androgen-deprivation therapy, a mainstay of prostate cancer treatment, may give prostate cells new growth abilities, scientists at Memorial Sloan Kettering have found.

… Thursday, April 30, 2020 Summary The prostate gland has a remarkable ability to regrow itself after hormone-deprivation therapy. A new study from researchers at Memorial Sloan Kettering explains why. The standard treatment for men with advanced prostate cancer is androgen-deprivation therapy. Androgens

A new imaging technology developed at MSK allows researchers to focus on genes as they are copied into messenger RNA.

… Friday, July 5, 2019 Summary For the first time, SKI investigators have found a way to peer inside living cells and observe gene transcription, the process by which DNA is copied into messenger RNA. A picture is worth a thousand words, or so the saying goes. But it can be quite a challenge to capture

The summer programs connect high school and medical school students with MSK faculty while offering the opportunity for student-to-student mentorship.

… Thursday, October 6, 2022 At the end of the summer, Memorial Sloan Kettering Cancer Center (MSK) concluded two of its annual research programs for students. Twenty medical school students completed the Summer Pipeline Program and 15 New York City high school students completed the Summer Exposure Program

The Nobel committee this week awarded its Prize in Physiology or Medicine to work focused on cancer, specifically, James P. Allison and Tasuku Honjo for their work on immune checkpoint blockade. Dr. Allison was a member of the Sloan Kettering Institute from 2004 to 2012.

… Thursday, October 4, 2018 The Nobel committee this week awarded its Prize in Physiology or Medicine to work focused on cancer, specifically, James P. Allison and Tasuku Honjo for their work on immune checkpoint blockade. Dr. Allison was a member of the Sloan Kettering Institute from 2004 to 2012. Unlike

A number of scientific breakthroughs have led to the development of drugs that unleash the power of the immune system to recognize and attack cancer. For Classical Hodgkin lymphoma patients, two phase I studies are already demonstrating dramatic results.

… Saturday, December 6, 2014 In recent years, a number of scientific breakthroughs have led to the development of drugs that unleash the power of the immune system to recognize and attack cancer. Studies presented today at the 56th Annual Meeting of the American Society of Hematology (ASH) highlight the

Human data and results from mouse experiments suggest that people with BRCA2 mutations may respond well to immunotherapy drugs.

… Monday, November 30, 2020 Summary Tumors with mutations in the BRCA2 cancer-predisposition gene respond better to checkpoint blockade immunotherapy than tumors with mutations in BRCA1 , scientists at Memorial Sloan Kettering have found. Treatments that harness the immune system to fight cancer have greatly

A clinical trial provides evidence that blocking a protein called PI3K can be an effective treatment strategy for breast cancer.

… Saturday, June 2, 2018 Summary Researchers have hoped that drugs blocking a disease pathway called PI3K will slow breast cancer growth. Now a phase III clinical trial testing a drug called taselisib in combination with hormone therapy shows that this strategy can be effective. One of the most inviting